The time interval from ADP receptor blocker loading dose administration to the sample collection was similar in T2D and ND patients in both examinations (sample 1: 1.8 ± 0.9 hours versus 1.7 ± 0.9 hours; sample 2: 21.6 ± 2.2 hours versus 20.0 ± 1.9 hours). Here, P2RY1 is linked to type 2 diabetes mellitus.